Atorvastatin Calcium
Product Images NDC 68071-4302

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-4302). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

68071 4302 9

Atorvastatin Calcium 20 mg tablets packaging label from NuCare Pharmaceuticals, Inc. The label indicates a package size of 90 tablets with the product number R1520090. It includes storage instructions to keep at controlled temperatures between 59-86°F and a warning to keep out of reach of children. The label also references manufacturer Apotex Inc. in Toronto, Ontario, Canada, and provides a contact number for reporting side effects to the FDA.*

FDA Label Image

Figure-01 (Figure 01)

A cumulative incidence line graph comparing Atorvastatin and Placebo over 3.5 years. The y-axis shows cumulative incidence percentage, and the x-axis shows time in years. The graph shows lower cumulative incidence for Atorvastatin versus Placebo, with a hazard ratio and p-value noted on the chart.*

FDA Label Image

Figure-02 (Figure 02)

A line graph comparing cumulative hazard percentages over time (up to four years) between placebo and atorvastatin groups. The graph shows time to first primary endpoint with placebo represented by a dashed line and atorvastatin by a solid line, indicating lower cumulative hazard for atorvastatin. A hazard ratio (HR) of 0.63 with confidence interval and p-value is displayed on the graph.*

FDA Label Image

Figure-03 (Figure 03)

A line graph depicting the percentage of subjects experiencing an event over time (years) comparing Atorvastatin 10 mg and 80 mg doses. The x-axis shows time to first major cardiovascular endpoint in years, and the y-axis shows the percentage of subjects experiencing the event. The graph includes a hazard ratio (HR 0.78) with confidence interval and p-value indicating statistical significance.*

FDA Label Image

Chemical-structure (Chemical Structure)

Chemical structure of the active ingredient atorvastatin calcium, showing its molecular arrangement including calcium ions and the atorvastatin moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.